Cargando…

Protocol for iGrow (Infant Growth and Development Study): biopsychosocial predictors of childhood obesity risk at 2 years

BACKGROUND: Childhood obesity remains a significant public health problem. To date, most research on the causes and correlates of obesity has focused on a small number of direct predictors of obesity rather than testing complex models that address the multifactorial nature of the origins of obesity...

Descripción completa

Detalles Bibliográficos
Autores principales: Leerkes, Esther M., Buehler, Cheryl, Calkins, Susan D., Shriver, Lenka H., Wideman, Laurie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734916/
https://www.ncbi.nlm.nih.gov/pubmed/33317498
http://dx.doi.org/10.1186/s12889-020-10003-0
_version_ 1783622557573840896
author Leerkes, Esther M.
Buehler, Cheryl
Calkins, Susan D.
Shriver, Lenka H.
Wideman, Laurie
author_facet Leerkes, Esther M.
Buehler, Cheryl
Calkins, Susan D.
Shriver, Lenka H.
Wideman, Laurie
author_sort Leerkes, Esther M.
collection PubMed
description BACKGROUND: Childhood obesity remains a significant public health problem. To date, most research on the causes and correlates of obesity has focused on a small number of direct predictors of obesity rather than testing complex models that address the multifactorial nature of the origins of obesity in early development. We describe the rationale and methods of iGrow (Infant Growth and Development Study) which will test multiple pathways by which (a) prenatal maternal psychobiological risk predicts infant weight gain over the first 6 months of life, and (b) this early weight gain confers risk for obesity at age 2. Infant hormonal and psychobiological risk are proposed mediators from prenatal risk to early weight gain, though these are moderated by early maternal sensitivity and obesogenic feeding practices. In addition, higher maternal sensitivity and lower obesogenic feeding practices are proposed predictors of adaptive child self-regulation in the second year of life, and all three are proposed to buffer/reduce the association between high early infant weight gain and obesity risk at age 2. METHODS: iGrow is a prospective, longitudinal community-based study of 300 diverse mothers and infants to be followed across 5 data waves from pregnancy until children are age 2. Key measures include (a) maternal reports of demographics, stress, well-being, feeding practices and child characteristics and health; (b) direct observation of maternal and infant behavior during feeding, play, and distress-eliciting tasks during which infant heart rate is recorded to derive measures of vagal withdrawal; (c) anthropometric measures of mothers and infants; and (d) assays of maternal prenatal blood and infant saliva and urine. A host of demographic and other potential confounds will be considered as potential covariates in structural equation models that include tests of mediation and moderation. Efforts to mitigate the deleterious effects of COVID-19 on study success are detailed. DISCUSSION: This study has the potential to inform (1) basic science about early life processes casually related to childhood obesity and (2) development of targeted intervention and prevention approaches that consider mother, infant, and family risks and resources.
format Online
Article
Text
id pubmed-7734916
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77349162020-12-14 Protocol for iGrow (Infant Growth and Development Study): biopsychosocial predictors of childhood obesity risk at 2 years Leerkes, Esther M. Buehler, Cheryl Calkins, Susan D. Shriver, Lenka H. Wideman, Laurie BMC Public Health Study Protocol BACKGROUND: Childhood obesity remains a significant public health problem. To date, most research on the causes and correlates of obesity has focused on a small number of direct predictors of obesity rather than testing complex models that address the multifactorial nature of the origins of obesity in early development. We describe the rationale and methods of iGrow (Infant Growth and Development Study) which will test multiple pathways by which (a) prenatal maternal psychobiological risk predicts infant weight gain over the first 6 months of life, and (b) this early weight gain confers risk for obesity at age 2. Infant hormonal and psychobiological risk are proposed mediators from prenatal risk to early weight gain, though these are moderated by early maternal sensitivity and obesogenic feeding practices. In addition, higher maternal sensitivity and lower obesogenic feeding practices are proposed predictors of adaptive child self-regulation in the second year of life, and all three are proposed to buffer/reduce the association between high early infant weight gain and obesity risk at age 2. METHODS: iGrow is a prospective, longitudinal community-based study of 300 diverse mothers and infants to be followed across 5 data waves from pregnancy until children are age 2. Key measures include (a) maternal reports of demographics, stress, well-being, feeding practices and child characteristics and health; (b) direct observation of maternal and infant behavior during feeding, play, and distress-eliciting tasks during which infant heart rate is recorded to derive measures of vagal withdrawal; (c) anthropometric measures of mothers and infants; and (d) assays of maternal prenatal blood and infant saliva and urine. A host of demographic and other potential confounds will be considered as potential covariates in structural equation models that include tests of mediation and moderation. Efforts to mitigate the deleterious effects of COVID-19 on study success are detailed. DISCUSSION: This study has the potential to inform (1) basic science about early life processes casually related to childhood obesity and (2) development of targeted intervention and prevention approaches that consider mother, infant, and family risks and resources. BioMed Central 2020-12-14 /pmc/articles/PMC7734916/ /pubmed/33317498 http://dx.doi.org/10.1186/s12889-020-10003-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Leerkes, Esther M.
Buehler, Cheryl
Calkins, Susan D.
Shriver, Lenka H.
Wideman, Laurie
Protocol for iGrow (Infant Growth and Development Study): biopsychosocial predictors of childhood obesity risk at 2 years
title Protocol for iGrow (Infant Growth and Development Study): biopsychosocial predictors of childhood obesity risk at 2 years
title_full Protocol for iGrow (Infant Growth and Development Study): biopsychosocial predictors of childhood obesity risk at 2 years
title_fullStr Protocol for iGrow (Infant Growth and Development Study): biopsychosocial predictors of childhood obesity risk at 2 years
title_full_unstemmed Protocol for iGrow (Infant Growth and Development Study): biopsychosocial predictors of childhood obesity risk at 2 years
title_short Protocol for iGrow (Infant Growth and Development Study): biopsychosocial predictors of childhood obesity risk at 2 years
title_sort protocol for igrow (infant growth and development study): biopsychosocial predictors of childhood obesity risk at 2 years
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734916/
https://www.ncbi.nlm.nih.gov/pubmed/33317498
http://dx.doi.org/10.1186/s12889-020-10003-0
work_keys_str_mv AT leerkesestherm protocolforigrowinfantgrowthanddevelopmentstudybiopsychosocialpredictorsofchildhoodobesityriskat2years
AT buehlercheryl protocolforigrowinfantgrowthanddevelopmentstudybiopsychosocialpredictorsofchildhoodobesityriskat2years
AT calkinssusand protocolforigrowinfantgrowthanddevelopmentstudybiopsychosocialpredictorsofchildhoodobesityriskat2years
AT shriverlenkah protocolforigrowinfantgrowthanddevelopmentstudybiopsychosocialpredictorsofchildhoodobesityriskat2years
AT widemanlaurie protocolforigrowinfantgrowthanddevelopmentstudybiopsychosocialpredictorsofchildhoodobesityriskat2years